Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-10-27

Clinical Trial Update: Comparative Efficacy of Two Preparations of the Association Diosmin (450 mg) + Hesperidin (50 mg) in the Treatment of Chronic Venous Insufficiency (CVI) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing two preparations of diosmin 450 mg plus hesperidin 50 mg for chronic venous insufficiency; no results or status details …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diosmin 450 mg + Hesperidin 50 mg combination (diosmin; hesperidin)

Snippet

Sponsor: Azidus Brasil | Conditions: Venous Insufficiency | Phase 3 | Status: UNKNOWN